- Home
- BZUN vs ABOS Comparison
BZUN vs ABOS Comparison
Compare BZUN & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- ABOS
- Stock Information
- Founded
- BZUN 2007
- ABOS 1996
- Country
- BZUN China
- ABOS United States
- Employees
- BZUN N/A
- ABOS N/A
- Industry
- BZUN Catalog/Specialty Distribution
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- BZUN Consumer Discretionary
- ABOS Health Care
- Exchange
- BZUN Nasdaq
- ABOS Nasdaq
- Market Cap
- BZUN 144.4M
- ABOS 72.7M
- IPO Year
- BZUN N/A
- ABOS 2021
- Fundamental
- Price
- BZUN $2.59
- ABOS $1.46
- Analyst Decision
- BZUN Buy
- ABOS Strong Buy
- Analyst Count
- BZUN 2
- ABOS 4
- Target Price
- BZUN $3.20
- ABOS $6.50
- AVG Volume (30 Days)
- BZUN 263.4K
- ABOS 623.5K
- Earning Date
- BZUN 08-27-2025
- ABOS 08-12-2025
- Dividend Yield
- BZUN N/A
- ABOS N/A
- EPS Growth
- BZUN N/A
- ABOS N/A
- EPS
- BZUN N/A
- ABOS N/A
- Revenue
- BZUN $1,310,110,798.00
- ABOS N/A
- Revenue This Year
- BZUN $5.27
- ABOS N/A
- Revenue Next Year
- BZUN $3.46
- ABOS N/A
- P/E Ratio
- BZUN N/A
- ABOS N/A
- Revenue Growth
- BZUN 6.77
- ABOS N/A
- 52 Week Low
- BZUN $2.11
- ABOS $0.86
- 52 Week High
- BZUN $4.38
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- BZUN 44.96
- ABOS 58.51
- Support Level
- BZUN $2.56
- ABOS $1.12
- Resistance Level
- BZUN $2.74
- ABOS $1.27
- Average True Range (ATR)
- BZUN 0.12
- ABOS 0.06
- MACD
- BZUN 0.01
- ABOS 0.00
- Stochastic Oscillator
- BZUN 53.46
- ABOS 77.78
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.